Artificial intelligence system created at UNC-Chapel Hill designs drugs from scratch
An artificial-intelligence approach created at Carolina could help bring new drugs to patients quicker.
An artificial-intelligence approach created at Carolina could help bring new drugs to patients quicker.
Carolina researchers are providing on-the-ground care to Ebola patients, monitoring Ebola survivors from the 2014 outbreak to learn more about the virus and testing an experimental drug for emergency treatment of patients infected with Ebola.
UNC-PrimeCare is working to address the needs of people across the life span, reaching out to serve rural and underserved communities and populations in North Carolina.
The $1.2 million gift will be used to accommodate more students, recruit top faculty and develop rural sites for students to participate in clinical rotations.